Lv4
420 积分 2023-09-19 加入
Navigating the Evolving Landscape of EGFR -Mutated NSCLC
1天前
已完结
Association between different stages of cardiovascular-kidney-metabolic syndrome and the risk of all-cause mortality
2个月前
已完结
Μetabolic dysfunction-associated steatotic liver disease: a condition of heterogeneous metabolic risk factors, mechanisms and comorbidities requiring holistic treatment
2个月前
已完结
Highlights from the 2025 ASCO Annual Meeting
3个月前
已完结
The Rise of Drug Innovation in China — Implications for Patient Access in the United States and Globally
3个月前
已完结
US Food and Drug Administration Approval Summary: Trastuzumab Deruxtecan for the Treatment of Adult Patients With Hormone Receptor–Positive, Unresectable or Metastatic Human Epidermal Growth Factor Receptor 2–Low or Human Epidermal Growth Factor Receptor 2–Ultralow Breast Cancer
5个月前
已关闭
Efficacy and safety of glucagon‐like peptide‐1/glucagon receptor co‐agonist JNJ ‐64565111 in individuals with type 2 diabetes mellitus and obesity: A randomized dose‐ranging study
5个月前
已完结
Efficacy and safety of glucagon‐like peptide‐1/glucagon receptor co‐agonist JNJ‐64565111 in individuals with obesity without type 2 diabetes mellitus: A randomized dose‐ranging study
5个月前
已完结
皖公网安备34019202002308
